 |
| MAY
8, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Alkeus Pharmaceuticals: Presents
Gildeuretinol Data During the Association for
Research in Vision and Ophthalmology (ARVO)
2025 Annual Meeting May 4-8, 2025 More
- Inari: Welcomes Agriculture Veteran Lisa
Nunez Safarian as Board Director More
- Marengo: Doses First Patient in STARt-002
Clinical Trial Evaluating First-in-Class Dual
T Cell Agonist, Invikafusp Alfa in Combination
With TROP2-directed ADC Trodelvy in Metastatic
Breast Cancer More
- NewBiologix: Licenses Xcell-Eng-HEK293 Cell
Line to ReciBioPharm for Development and
Manufacture of Adeno-Associated Virus (AAV)
Therapeutics More
- TransCode Therapeutics: Successfully
Completes Initial Dosing of Patients in Cohort
4 of Phase 1a Clinical Trial; No Dose Limiting
Toxicities Reported More
- TRIANA Biomedicines: Appointment of
Caroline Germa as Chief Medical Officer and
Attracts Leading Drug Discovery and
Development Expert to its Scientific
Advisory Board More
- Viridian Therapeutics Receives FDA
Breakthrough Therapy Designation for
Veligrotug for the Treatment of Thyroid Eye
Disease (TED) More
|
|
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
- Amylyx Pharmaceuticals: First Quarter 2025
Financial Results More
- Cullinan Therapeutics: Corporate Update and
Reports First Quarter 2025 Financial Results More
- Dyne Therapeutics: First Quarter 2025
Financial Results and Recent Business
Highlights More
- Entrada Therapeutics: First Quarter 2025
Financial Results More
- Generation Bio: Recent Business Highlights
and First Quarter 2025 Financial Results More
- HilleVax: First Quarter 2025 Financial
Results and Highlights Recent Company Progress
More
- Intellia Therapeutics: First Quarter 2025
Financial Results and Highlights Recent
Company Progress More
- Korro: First Quarter 2025 Financial Results
and Provides Business Updates More
- Merus: Financial Results for the First
Quarter 2025 and Provides Business Update More
- Monte Rosa Therapeutics: First Quarter 2025
Financial Results and Business Updates More
- More on Sarepta Being Slammed By Double
Blow: Elevidys Sales Miss, Prasad’s CBER
Appointment More*
More
More
- Myomo: First Quarter 2025 Financial and
Operating Results More
- Nuvalent: Outlines Recent Pipeline and
Business Progress, Reiterates Key Anticipated
Milestones, and Reports First Quarter 2025
Financial Results More
- PepGen: First Quarter 2025 Financial Results
and Recent Corporate Highlights More
- Q32 Bio: First Quarter 2025 Financial
Results and Provides Corporate Update More
- Rapport Therapeutics: First Quarter 2025
Financials and Provides Business Update More
- Sale in Bedford Makes Way for
Biomanufacturing Conversion More*
More
- Twist Bioscience and Ginkgo Bioworks: Revise
Collaboration More
- 2seventy bio: First Quarter Financial
Results and Provides Update on Proposed
Acquisition by Bristol Myers Squibb More
- Wave Life Sciences: First Quarter 2025
Financial Results and Provides Business Update
More
- Werewolf Therapeutics: First Quarter 2025
Financial Results and Provides Business Update
More
- Xilio Therapeutics: Pipeline and Business
Updates and First Quarter 2025 Financial
Results More
- Zai Lab: First Quarter 2025 Financial
Results and Recent Corporate Updates More
|
|
|
- After Big Acquisition, Biogen Looks to Set
Up West Coast Hub in South San Francisco More*
- Broad: How the Novo Nordisk Foundation
Center is Using Scalable Technologies and AI
to Find the Root Cause of Diabetes More
- Leveraging Synergies: How a Merger
Provides Speed, Flexibility, and a Unified
Offering for Customers Podcast
- Moderna Faces PMCPA Audit Over 'Completely
Unacceptable' Lack of Transparency More
- More on Charles River Launching
'Strategic Review' Alongside Activist
Investor Elliott More*
More*
More
- More on CRISPR Therapeutics Seeing 80% Fall
in LDL, Triglycerides After In Vivo Liver
Editing More
- Petri Dish: Cancer Biotech Cuts Staff;
Lantheus Sells Business Unit More*
- Recent Federal Actions Put US, Massachusetts
Biotech Leadership at Risk: MassBio More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems More
- OPPORTUNITY: West Coast Business Development
Director More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
